PPI-01

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NamePPI-01
Drug Alias Namehypercholesterolemia drug (Phaedrus)PPI-01
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionApolipoprotein E modulators
TargetsApolipoprotein E
Therapy Area/IndicationsHypercholesterolemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPhaedrus Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsHypercholesterolemia

Other Information

ATC CodeN/A
Related LinksN/A